Suspension of trading
Valuation Atrion Corporation
Stocks
ATRI
US0499041053
Medical Equipment, Supplies & Distribution
|
Delayed
Nasdaq
16:00:00 2024-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 459.92 USD | +0.06% |
|
-.--% | - |
| 24-08-22 | Atrion Corporation(NasdaqGS:ATRI) dropped from S&P Healthcare Equipment Select Industry Index | CI |
| 24-08-22 | Atrion Corporation(NasdaqGS:ATRI) dropped from S&P TMI Index | CI |
Company Valuation: Atrion Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,373 | 1,394 | 1,175 | 1,269 | 991.7 | 666.6 |
| Change | - | 1.52% | -15.73% | 8.06% | -21.87% | -32.78% |
| Enterprise Value (EV) 1 | 1,305 | 1,326 | 1,133 | 1,208 | 966.5 | 660.6 |
| Change | - | 1.61% | -14.52% | 6.61% | -20% | -31.65% |
| P/E | 40.2x | 38.1x | 36.8x | 38.8x | 28.6x | 34.4x |
| PBR | 6.52x | 5.86x | 4.88x | 5.2x | 4.11x | 2.74x |
| PEG | - | 5.45x | -3.2x | 9.14x | 3.77x | -0.8x |
| Capitalization / Revenue | 9.01x | 8.99x | 7.96x | 7.69x | 5.4x | 3.94x |
| EV / Revenue | 8.56x | 8.55x | 7.68x | 7.32x | 5.27x | 3.9x |
| EV / EBITDA | 25.7x | 25.8x | 23.9x | 24.7x | 18.1x | 17.5x |
| EV / EBIT | 31.3x | 32.7x | 31.8x | 33.5x | 24.4x | 29.3x |
| EV / FCF | 82.9x | 156x | 129x | 71.2x | -140x | -54.4x |
| FCF Yield | 1.21% | 0.64% | 0.78% | 1.4% | -0.71% | -1.84% |
| Dividend per Share 2 | 5.1 | 5.8 | 6.6 | 7.4 | 8.2 | 8.7 |
| Rate of return | 0.69% | 0.77% | 1.03% | 1.05% | 1.47% | 2.3% |
| EPS 2 | 18.44 | 19.73 | 17.44 | 18.18 | 19.56 | 11.02 |
| Distribution rate | 27.7% | 29.4% | 37.8% | 40.7% | 41.9% | 78.9% |
| Net sales 1 | 152.4 | 155.1 | 147.6 | 165 | 183.5 | 169.3 |
| EBITDA 1 | 50.83 | 51.38 | 47.32 | 48.93 | 53.5 | 37.68 |
| EBIT 1 | 41.71 | 40.53 | 35.67 | 36.04 | 39.69 | 22.58 |
| Net income 1 | 34.26 | 36.76 | 32.12 | 33.06 | 35.01 | 19.41 |
| Net Debt 1 | -68.44 | -68.25 | -41.44 | -61.23 | -25.21 | -6.016 |
| Reference price 2 | 741.08 | 751.50 | 642.24 | 704.90 | 559.45 | 378.79 |
| Nbr of stocks (in thousands) | 1,853 | 1,855 | 1,829 | 1,801 | 1,773 | 1,760 |
| Announcement Date | 2/26/19 | 3/2/20 | 3/1/21 | 2/25/22 | 2/27/23 | 2/29/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 809M | ||
| 28.88x | 3.99x | 15.42x | 2.52% | 176B | ||
| 19.24x | 3.52x | 12.58x | 3.12% | 116B | ||
| 17.61x | 0.2x | 12.86x | 0.74% | 61.36B | ||
| 27.83x | 6.83x | 17.6x | 1.44% | 49.42B | ||
| 34.27x | 3.34x | 11.43x | 2.21% | 48.44B | ||
| 33.28x | 5.85x | 18.35x | -.--% | 31.33B | ||
| 42x | 1.24x | 11.46x | 0.22% | 28.56B | ||
| 40.38x | 7.07x | 25.37x | 0.26% | 24.37B | ||
| 16.74x | 2.67x | 9.46x | 1.65% | 21.57B | ||
| Average | 28.91x | 3.86x | 14.95x | 1.35% | 55.86B | |
| Weighted average by Cap. | 26.96x | 3.72x | 14.56x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRI Stock
- Valuation Atrion Corporation
Select your edition
All financial news and data tailored to specific country editions
















